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Abstract
Stem cells offer the basis for the promotion of robust new therapeutic approaches for a vari-
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ety of human disorders. There are still many limitations to be overcome before clinical therapeutic application, including a better understanding of the mechanism by which stem cell
therapies may lead to enhanced recovery. In vitro investigations are necessary to dissect the
mechanisms involved and to support the potential development in stem cell-based therapies.
In spite of growing interest in human amniotic fluid stem cells, not much is known about the
characteristics of their secretome and regarding the potential neuroprotective mechanism in
different pathologies, including stroke. To get more insight on amniotic fluid cells therapeutic
potential, signal transduction pathways activated by human amniotic fluid stem cells (hAFSCs)derived secretome in a stroke in vitro model (ischemia/reperfusion [I/R] model) were investigated by Western blot. Moreover, miRNA expression in the exosomal fraction of the
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conditioned medium was analyzed. hAFSCs-derived secretome was able to activate pro-
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In particular, the pathways of relevance in ischemia/reperfusion, such as neurotrophin signaling,

Liborio Stuppia, MD, Department of
Psychological, Health and Territorial Sciences,
School of Medicine and Health Sciences, “G.
d'Annunzio” University, Chieti-Pescara, Italy.
Email: stuppia@unich.it

survival and anti-apoptotic pathways. MicroRNA analysis in the exosomal component revealed
a panel of 16 overexpressed miRNAs involved in the regulation of coherent signaling pathways.
and those related to neuroprotection and neuronal cell death, were analyzed. The results
obtained strongly point toward the neuroprotective effects of the hAFSCs-conditioned medium
in the in vitro stroke model here analyzed. This can be achieved by the modulation and activation of pro-survival processes, at least in part, due to the activity of secreted miRNAs.
KEYWORDS

amniotic fluid, brain-derived neurotrophic factor, cerebral ischemia, conditioned medium,
exosome, ischemia-reperfusion, miRNA, oxygen-glucose deprivation, stem cells, stroke
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I N T RO DU CT I O N
Significance statement

Stroke is one of the primary causes of death and long-term disability
in the world and represents a major public health problem. Stroke can
be categorized into two major types, specifically ischemic and hemorrhagic stroke. Ischemic stroke is due to a block within a blood vessel
distributing blood to the brain, while hemorrhagic stroke is due by the
rupture of a blood vessel or an irregular vascular construct.1,2
stroke.3 Cerebral ischemia leads to different detrimental effects,
including oxidative stress, ionic imbalance, apoptosis, and inflammation, which cause neuronal impairment and death.4 This pathology
lacks successful cures, due to both the limited time window for intervention before the development of deleterious consequences, and
the absence of specificity of the treatments established so far. Furthermore, the inhibition of some molecular targets demonstrates to
be ineffective due to secondary effects. To date, tissue plasminogen

amniotic fluid stem cells (hAFSCs)-derived secretome in an
ischemia/reperfusion in vitro model. Interestingly, in the
presented experimental conditions, hAFSCs-derived secretome was able to activate pro-survival and anti-apoptotic
pathways. Furthermore, microRNA analysis in the exosomal
component revealed overexpressed miRNAs involved in
neurotrophin signaling and those related to neuroprotection
and neuronal cell death. In light of the data obtained, the
use of conditioned medium and, in particular, exosomes,
may constitute a potential approach to stimulate neuronal
plasticity, ameliorate cognitive loss and neural replacement,
and may represent a suitable treatment for ischemia/reperfusion injury.

activator is the only therapeutic approach used in stroke patients.4-6
Reperfusion injury occurring in consequence of ischemic stroke is an
intricate process involving several processes. Also, thrombolytic ther-

The amniotic fluid is a protective liquid for fetus growth and

apy itself can lead to brain injuries, named cerebral ischemia/reperfu-

offers mechanical support as well as essential nutrients during

sion (I/R) injury.7,8 I/R injury is one of the major reasons for disability,

embryogenesis.24 It is constituted primarily of water, cells, and chemi-

high morbidity, and mortality worldwide. Due to the lack of effective

cal elements.25 These cells are heterogeneous in morphology, in vitro,

neuroprotective treatments, the care for I/R injury continues to be a

and in vivo characteristics.26 They are mainly of fetal derivation (respi-

main medical concern and needs to be thoroughly investigated.

ratory, epithelial, urinary, and intestinal tract), but also amniotic mem-

Due to its characteristics, the oxygen and glucose deprivation

branes and connective tissues. Furthermore, the amniotic fluid

(OGD) challenge of neurons is a useful model of cerebral ischemia and

presents various cellular subcategories (amniotic, fibroblastic, and epi-

provides the analysis of molecular pathways underlying stroke.9-11

thelioid), which differ in percentage depending on gestational

This challenge entails placing the cells in a glucose-free medium in an

period.27 Amniotic fluid mesenchymal stem cells (AFMSCs) are really

anaerobic condition; thus, merging the lack of these two components

attractive due to their potential therapeutic purposes, and numerous

mimics the clinical situation in the brain during cerebral ischemia but

procedures of expansion and isolation have been reported. AFMSCs

in a simplified system.11,12 Successively, to mimic in vitro the I/R

show a wide differentiation potential toward mesenchymal lineages

injury, the OGD model is subjected to reperfusion (OGD/R or I/R) in

and have the capability to differentiate toward chondrogenic, osteo-

normoxia condition.13

genic, and adipogenic, thus representing a suitable cell source for

Differentiated SH-SY5Y are widely accepted for in vitro experi-

regenerative and therapeutic approaches.28

ments requiring neuronal-like cells. Differentiated SH-SY5Y are low

However, two processes exerting a crucial part in regenerative

cost to culture, and the ethical concerns related with primary human

processes are reported. One process concerns the differentiation of

neuronal culture are avoided. Furthermore, since SH-SY5Y cells are

the engrafted stem cells toward the specific cytotype of the injured

human-derived, they express several human-specific proteins and

area. This mechanism has been depicted by different authors,29-32 but

isoforms that would not be inherently present in rodent primary cul-

the small amount of exogenous cells constantly and directly engrafted

tures.14,15 Particularly, this cell line is used to develop the in vitro

into the regenerated tissue do not entirely clarify the achieved regen-

OGD/IR model.15-21

erative effect. The incomplete integration may be due to the

Current findings in regenerative medicine have strengthened the

heterogenic level of pre-differentiation produced in vitro before the

search for new stem cell sources with beneficial properties; in particu-

transplant. In fact, the entire cell population stimulated might not

lar, amniotic fluid has been identified as a valid resource of stem cells

undertake the differentiation process. This subpopulation could pre-

in this field. Adult stem cells, even after reprogramming, could pre-

serve low immunogenic characteristics but, notably, can influence the

serve epigenetic alterations, thus representing a limitation in their

immune system and promote the recruitment of resident progenitor

application.22 On the other hand, fetal stem cells may overcome this

cells to regenerate injured tissue. Numerous investigations corrobo-

limitation, and furthermore, ethical issues related to its isolation are

rated this hypothesis, indicating the protective activity of the stem

minimal, in particular regarding amniotic fluid stem cells, as they are

cell-released molecules alone (conditioned medium) in the regenera-

collected during routine amniocentesis, third-trimester amnio-

tion of the damaged area where, typically, a chronic inflammation con-

reduction or cesarean section.23

dition is present.33-36
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Founding on these theories, in the last decade, more interest has

(Sigma-Aldrich) that had been deoxygenated with an anaerobic gas

been focused on stem cells secretome and, consequently, on the para-

mixture (0.1% O2) for 30 minutes before use. Cells were then incu-

Conditioned medium (CM) consists of extracellular

bated in a hypoxic condition incubator, 0.1% O2 at 37 C at different

vesicles (EV) and soluble factors. Recently, besides exerting role as

time points. To set the experimental conditions, we measured cell via-

biomarkers, secreted EV has been included among the players pro-

bility after different OGD timepoints. In particular, 3 hours OGD insult

moting mesenchymal stem cells (MSCs) regenerative potential40-43

showed a 50% reduction in cell viability and was chosen for the fol-

although, so far, a complete molecular description of their “cargo” is

lowing experiments.

37-39

crine effect.

lacking.

2.1.2

|

I/R model

electron microscope. Recently, different investigations were focused
on exosomes for their cell-to-cell communication, storage of biological

We set 3 hours OGD as timepoint, then to perform reperfusion condi-

information, the use as biomarkers, and, in particular, for the potential

tions, medium was substituted with DMEM (for I/R control) or condi-

application in regeneration and neural protection.44-46 Exosomes have

tioned medium (I/R + CM), and cells were incubated for 24 hours in

cup-shaped morphology and derive from the endocytic pathway after

95% air/5% CO2 in a humidified incubator (reperfusion). Control cells

the fusion of multivesicular bodies with the plasma membrane and

were exposed to the identical experimental processes with vehicle

then release into the extracellular environment.44

only and with no exposure to anoxia and glucose-free medium

Exosomes contain several proteins, miRNA, DNA, saccharides,
and lipids, indicated with the term “cargo.”

47,48

Because of their nano-

size and non-complexed structure, exosomes efficiently cross the

(Normoxia). About 24 hours after OGD/Reperfusion we assayed again
the cell viability to understand if conditioned media could exert positive effects.

blood-brain barrier, consequently, represent innovative approaches to
design therapeutic strategies for different cerebral diseases. Thus,
exosomes offer an alternative therapeutic approach as a substitute for

2.1.3

|

CM preparation

cell transplantation.49
On these bases, in the present work, the signal transduction path-

Cells used to collect the conditioned medium were approved by the

ways activated by hAFSCs-secretome on a stroke in vitro model (I/R)

ethic committee for biomedical research of the G. D'Annunzio

and the main miRNA involved in the modulation of the observed

University of Chieti-Pescara, Italy. Two milliliters of amniotic fluid

effects were investigated, shedding light on some of the possible

were collected after informed written consent and centrifuged at

mechanisms of hAFSCs-induced neuroprotection.

1200 rpm for 5 minutes and the pellet was utilized to establish the
cell line.51
hAFS cells were cultivated in Iscove's Modified Dulbecco's medium

2

MATERIALS AND METHODS

|

(Corning), complemented with 10% FBS (Corning), 100 μg/mL streptomycin, 100 U/mL penicillin, 2 mM l-glutamine (Corning), and 5 ng/mL

2.1

Cell culture and treatments

|

basic FGF 2 (Peprotech, United Kingdom), and cultured at 37 C in a
humidified atmosphere with 5% CO2. The medium was replaced every

The human neuroblastoma cell line SH-SY5Y has comparable elec-

2 days.

trophysiological, morphological, and neurochemical characteristics

To collect conditioned medium, when the culture reached the

of neurons and was bought from the European Collection of

confluence of 70% the medium was replaced with IDMEM sup-

Authenticated Cell Cultures.Cells were maintained in DMEM high-

plemented with exosome-free FBS (depleted using a kit by Norgen

glucose medium complemented with 10% FBS and 1% antibiotics

Biotek, Canada) and collected after 72 hours.

(Corning) and were maintained in a humidified condition with 5%
carbon dioxide at 37 C. Cells were seeded at 104 cells/cm2; after
24 hours, to induce differentiation, medium was replaced with

2.1.4

|

Exosome preparation

DMEM 1% FBS, and N2 supplement (Gibco) for 7 days, as previously reported,50 and then subjected to OGD. Differentiated SH-

To isolate and purify the conditioned media exosomes different

SY5Y are widely accepted for in vitro experiments requiring

ultracentrifuge procedures were performed. Briefly, the condi-

neuronal-like cells.

17

tioned media were subjected to centrifuge for 5 minutes at 200g,
then 10 minutes at 200g in order to remove cell debris. Then, the
supernatant was collected and centrifuged for 30 minutes at

2.1.1

|

OGD model

16 500g (+4 C); the supernatant was again collected and centrifuged at 120 000 g for 90 minutes (+4 C). The pellet obtained

In brief, cells were gently rinsed with phosphate-buffered saline, and

contains the exosomes and was washed with Ultrapure water

the medium was substituted with EBSS containing L-glutamine

(90 minutes, 120 000g at 4 C).
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2.2

|

MTS assay

buffered saline with Tween for 1 hour at RT. Membranes were then
incubated overnight at 4 C with the below primary antibodies, pre-

Cell viability at different time points and conditions were determined,

pared in blocking buffer: rabbit anti-HIF-1α 1:200 (Santa Cruz); rabbit

using Cell Proliferation Assay (Promega) a colorimetric assay

anti-BDNF 1:1000 (Abcam, United Kingdom); rabbit anti-p-TrkB and

established on the amount of formazan produced, as a function of via-

TrKB 1:500 (Abcam, United Kingdom); rabbit anti-p-ERK5 and ERK5

bility. The assay was read at 490 nm using a plate reader, Infinite

1:1000 (Cell Signaling), rabbit anti PSD95 1:1000 (Cell Signaling); rab-

F200 (Tecan, Swiss), and analyzed in triplicate.

bit anti-p-CREB and CREB 1:1000 (Cell Signaling), rabbit anti P75
1:1000 (Abcam, United Kingdom); mouse anti-RhoA 1:500 (Santa

|

Immunofluorescence

ProBDNF 1:500 (Invitrogen). After extensive washings, membranes
were incubated with peroxidase-conjugated anti-rabbit or mouse IgG

Treated and untreated cells were fixed in 4% paraformaldehyde in

(1:10 000; Vector Laboratories). To visualize, the immunoreactive

PBS for 15 minutes at RT and permeabilized in cold methanol for

bands were incubated with luminol (Bio-Rad Laboratories), according

15 minutes. Unspecific sites were blocked using 4% BSA for

to the producer's directions. The bands were revealed using Uvitec

20 minutes. As primary antibody, rabbit anti-NHF (1:200, Invitrogen

(United Kingdom) machine and digital images were collected. To

by Thermo Fisher Scientific) diluted in bovine serum albumin was

reprobe the same membrane, ReBlot Plus Strong Antibody Stripping

used. Cells were then washed with PBS thoroughly and then incu-

Solution was used following manufacturer's protocol (Sigma). Relative

bated with the secondary antibody, goat anti-rabbit conjugated with

densities were analyzed using Fiji software and to normalize and

Alexa Fluor 633 (1:2000; Life Technologies) for 40 minutes. Cover-

check the loading, HRP-conjugated actin was used (Cell signaling).

slips were thoroughly washed, Vectashield mounting medium with

Phosphorylated proteins are normalized upon their respective total

DAPI (Vector Laboratories) was used, and then observed at fluores-

protein. Values were reported as relative units.

cence microscopy AXIOPHOT (Zeiss microscope, Germany).

2.7
2.4

|

|

BDNF ELISA kit

Neurite analyses
mBDNF ELISA kit was purchased from Aviscera Bioscience, United

Neuronal cells were photographed from 8 to 10 random fields per

States. Both the exosome component and liquid component were

coverslip from three independent experiments using an immunofluo-

separated by ultracentrifugation. Then we assayed the kit following

rescence microscope (AXIOPHOT, Zeiss microscope). Cell clusters

the manufacturer's protocols and finally, we read the optical density,

were excluded from morphometric analyses. Neurite length was

using a microplate reader set to 450 nm. Data were expressed as

defined as the distance from the soma to the tip of the longest pri-

mBDNF (pg/mL).

mary neurite. Cells were traced using NeuronJ (plugin of Fiji software).
The neurite length was then divided on soma diameter (cell body). All
the detailed points can be found in the article by Pemberton et al,

2.8

|

RNA extraction and miRNAs analysis

52

2018.

Total RNA was extracted from CM exosomes, obtained as above
described, and exosome-free control medium using the Plasma/Serum

2.5

|

Protein assay

RNA Purification Mini Kit (Norgen Biotek, Canada) according to the
manufacturer's instructions.

Protein amount was assayed using Pierce BCA Protein Assay (Pierce)

MiRNAs analysis in exosomal component was investigated by
quantitative Real-Time PCR (qRT-PCR) using TaqMan Advanced

and the absorbance was read at 550 nm.

miRNA Human Serum/Plasma Card (Applied Biosystem). This method
allows evaluating the expression of 188 miRNAs, each of them in

2.6

|

Western blotting

duplicate, with high sensitivity and specificity starting from a very low
amount of total RNA input.

Treated and untreated cell cultures were collected and lysated in ice53,54

The analysis was performed by examining 2 replicates, by using

Protein lysates

RNAs extracted by two distinct CM-exosome preparations compared

(30-40 μg) were run on 9-13% SDS-polyacrylamide gel and blotted on

with control medium. Comparative expression analysis was performed

polyvinyldifluoride membrane (PVDF; Sigma-Aldrich). Regarding the

by QuantStudio Software v 1.3 and Expression Suite software v 1.3

extraction of proteins from CM and EXO components, RIPA buffer

(Applied Biosystems). Ath-miR159a was used as exogenous control

was used as the above described, and then 50 μg of protein content

for normalization of data, and global normalization analysis was con-

was run on gradient SDS gel (Thermo). Unspecific sites were blocked

ducted as well. ΔΔCt method was applied to determine the relative

in 5% lyophilized blocking buffer Blotto (Santa Cruz) diluted in Tris-

miRNAs expression levels. Furthermore, manual analysis focused on

cold RIPA buffer, as previously reported.
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PCR amplification plots profiles was performed, and miRNAs showing

by oxygen-dependent degradation. Indeed, in our experimental condi-

mean Ct less than 30 and relative quantification (RQ) values more

tion, it is possible to appreciate that the protein level is significantly

than twofold (linear scale) were considered.

increased in the OGD condition compared to normoxia (Figure 1C).
Regarding the reperfusion, 24 hours time point was chosen,
and different percentages of hAFSCs-conditioned medium were

2.9

In silico target genes and pathways analysis

|

tested. In Figure 1D, it is possible to appreciate that the conditioned medium significantly increased cell viability respect to the
control reperfusion. To confirm these data and show a similarity in

fied were performed using DIANA miRPath v.3 software (http://snf-

hAFSCs-derived CM, its therapeutic effect in primary culture was

515788.vm.okeanos.grnet.gr/).55 We used Tarbase analysis,56 which

conducted, in particular preliminary experiments on rat cortical

provide data about experimentally supported target genes and path-

neurons were performed as reported in File S1. Once we confirmed

ways and KEGG database annotation with standard statistics and

the protective effect and the similarity with our I/R model, to bet-

genes union settings for exploratory functional analysis. Graphs of

ter understand the “protective” mechanism, the pathways involved

miRNAs/target genes interactions were obtained by R software

in ischemia-reperfusion injury in differentiated SH-SY5Y I/R model

(www.r-project.org).

were dissected.

2.10

3.3

|

Statistical analyses

|

Protective mechanism analyses

Data were reported as means ± SE (n = 3). Statistical analysis was per-

To investigate the potential mechanisms underlying the conditioned

formed through Graphpad software, and data were evaluated using

media protective effects, the BDNF pathway upon both normoxic and

one-way analysis of variance. The level of significance was set

I/R conditions, by Western blot analysis was examined.

at P < .05.

Evidence demonstrated that BDNF resulted in increased neuronal
survival via anti-apoptotic effect.53,58-60 Accordingly, in Figure 2A, it is
possible to appreciate that the conditional medium can increase

3

RESULTS

|

mature BDNF protein level respect to the reperfusion with normal
media.

3.1

|

Phenotypic characterization of the hAFSCs

BDNF exerts multiple biological actions through TrkB (tropomyosin

receptor

kinase)

receptors,

it

binds

TrkB

triggering

The hAFSC line used for this study was assessed for various intracel-

autophosphorylation of the tyrosine residue in its intracellular domain,

lular and surface markers to determine that the cells are in an interme-

inducing ligand-induced dimerization in each receptor, which triggers

diary state between pluripotent stem cells and lineage-limited adult

numerous intracellular signaling cascades with many roles; three

progenitor cells. As previously described,51 the hAFSCs do not

enzymes represent the key regulators: mitogen-activated protein

express hematopoietic surface markers (ie, CD34, CD14, and CD45),

kinase (MAPK), phosphatidylinositol-3 kinase (PI3K), and phospholi-

while showing different mesenchymal markers (ie, CD90, CD73, and

pase C γ (PLCγ).53,58

CD105), numerous related surface adhesion molecules (ie, CD146,

In our experimental condition, also TrkB protein levels were sig-

CD44), and stemness markers, such as Sox-2, SSEA-4, and Oct3/4

nificantly increased upon conditioned medium treatment, as well as

(Data already published51).

the active forms of CREB (cAMP response element-binding protein)
and ERK5 (Extracellular signal Regulated kinase 5), all of which are
involved in neuronal survival pathways (Figure 2A).

3.2

|

I/R model

Therefore, it has been examined whether the conditioned mediadriven increase of BDNF and TrkB translated into variations in PSD95

To establish the I/R model, differentiated SH-SY5Y cells (using N2

(postsynaptic density protein 95) levels, a marker of post-synaptic

supplement, as explained in the method section) were subjected to

integrity. It is possible to observe a significative increase in the PSD95

OGD for 1 hour, 3 hours, 6 hours, or 12 hours. MTS assay revealed

protein level upon CM reperfusion (Figure 2A). PI3K/Akt signaling

that cell viability gradually diminished with increasing OGD time

pathway was also analyzed and, as it is shown in the same figure

(Figure 1A). Data confirmed also by contrast phase microscopy ana-

(Figure 2A), the conditioned medium was able to restore stroke-

lyses (Figure 1B). About 3 hours OGD insult showed a 50% reduction

induced decrease.

in cell viability and was chosen for the following experiments. To fur-

Further, it has been examined whether the observed neuro-

ther validate the model, the hypoxia inducible factor (HIF), a transcrip-

protective effect of the BDNF-TrkB signaling was related to alter-

tional activator that directs evolutionarily conserved adaptive

ations in the proBDNF-p75NTR signaling cascade. WB analysis of

reactions to hypoxia,12,57 was assayed by Western blotting. HIF is

these pathways confirmed that compared to control reperfusion, CM

induced in cerebral ischemia and the heterodimer HIF1α is regulated

treatment promoted a strong decrease in p75NTR levels as well as in
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proBDNF levels, paralleled with low levels of phosphorylated (active

Afterward, to compare to the whole conditioned media with the
exosomal fraction, the viability assay on the same model, treating the

form) of JNK (p-JNK) (Figure 2B).
Rho family GTPases received substantial appreciation as regula-

cells with the soluble component (CM w/o EXO) and the exosome

tors of actin cytoskeletal organization. In addition, Rac and/or Rho

extract (EXO) was performed. It is possible to notice in Figure 4A that,

GTPase dysregulation has been described in different neuronal inju-

compared to I/R control, both the components increased cell viability,

ries and neurodegenerative disorders, including I/R. Normally, Rac and

but the exosomal fraction (EXO) more significantly than the soluble

its downstream effectors stimulate neuronal survival, while Rho and

component (CM w/o EXO).

its downstream effectors can induce neuronal apoptosis.61-63 Indeed,

Further, mature BDNF levels through ELISA kit in whole CM, exo-

in our experimental conditions, a strong decrease in RhoA protein

somal component, and CM without exosomes were analyzed. Inter-

levels upon conditioned media reperfusion was observed, while both

estingly, elevated levels of mBDNF in CM and exosomal components

Rac and Cdc42 are significantly increased, as it is shown in Figure 2B,

(EXO) compared to the control medium were observed (Figure 4B);

thus, suggesting a protective role exerted by the CM.

these data were also confirmed by Western blot analysis in proteins

In

Figure

3,

immunofluorescence

analyses

for

NFH

(Neurofilament Heavy) is reported. Interestingly, upon CM reper-

extracted from exosomes compared to CM w/o EXO (Figure 4C).
miRNAs

expression

profile

in

conditioned

media-derived

fusion, a restore of neurite branches was observed, and this is

exosomes was examined to investigate a possible role of miRNAs as

even more evident in the graph, in which the length of the neu-

an exosomal component involved in the neuroprotective effects.

rites was compared with the diameter of the soma. In fact, in

Among the miRNAs analyzed, we identified 16 hyper-expressed

control I/R, a significant neurites length reduction was observed,

miRNAs in CM hAFSC-derived exosomes; these included let-7a-5p,

while, upon CM reperfusion, the length of the neurites was

let-7f-5p, let-7g-5p, miR-146a-5p, miR-154-5p, miR-155-5p, miR-

sharply increased, thus, suggesting that the CM exerted neuro-

221-3p, miR-222-3p, miR-22-3p, miR-23a-3p, miR-24-3p, miR-27a-

protective activities.

3p, miR-28-5p, miR-29a-3p, miR-31-5p, miR-34a-5p (Figure 4D).
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F I G U R E 1 A, Viability test upon
different OGD timepoints. B, Contrast
phase representative pictures of
differentiated SH-SY5Y upon normoxia
and OGD conditions. Bar = 20 μm. C,
Western blotting and relative
densitometric analysis for HIF-1α. D,
Viability test upon different concentration
of CM. Results are mean ± SE of
3 experiments (n = 3). *P < .05, **P < .005,
***P < .0005 vs Normoxia; +++P < .0005
vs I/R. Representative WB images are
shown
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In some of the miRNA assays, wide error bars can be detected,

such networks of genes overall targeted by miRNAs here considered,

arguably due to the nature of samples subjected to analysis, obtained

both pro-survival/proliferation and apoptotic or inflammatory signals

from heterogeneous, and most probably variable, secreted exosomal

inhibition would be induced but contextually, fine-tuned too.

components.

With this regard, we focused on the analysis of four of the most

Pathway-based analysis, predicting the putative biological func-

interesting pathways listed in Table 1: HIF-1 signaling, apoptosis, and

tions of the 16 miRNAs, suggested their involvement in a high number

neurotrophin signaling pathway and PI3K signaling. In Figures 5 and 6,

of KEGG signaling pathways (File S2). Among them, we focused on

pathways representations and miRNA/target genes interactions are

pathways relevant in I/R model, such as neurotrophin signaling and

reported, while relative target gene lists in File S4 are reported. Of

other pathways related to neuroprotection and neuronal cell death

note, most of the genes involved in the HIF-1 signaling pathway were

(Table 1).

targeted by the 16 miRNAs here identified, with consequent exten-

Further, we generated the list of experimentally supported target
genes (unique n = 582) involved in the pathways mentioned above

sive putative down-regulation possibly driving to a global pathway
switching off (Figure 5A).

(File S3). Among them, several genes are known to play a role in

Effects leading to apoptosis and inflammation may be deduced by

inducing cell proliferation and survival (eg, PI3K, AKT, RAS, ABL, SHC,

observing the apoptosis pathway map, where a relevant number of

BCL2, NF-kB), on the contrary, others are involved in negative regula-

target genes (Figure 5, complete list in File S4) with physiological pro-

tion of the signals mentioned above (eg, BAX, MAPK8, CDC42, RAC1,

apoptotic and pro-inflammatory functions, here supposed to be

GSK3B, JUN, TP53). Consequently, depending on the specific role in

downregulated, are shown. Interactions among the target mentioned
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F I G U R E 2 A, Western blotting and relative densitometric analysis for the neuroprotective pathway. Results are mean ± SE of 3 experiments
(n = 3). *P < .05, **P < .005 vs Normoxia; +P < .05, ++P < .005 vs I/R. Representative WB images are reported. B, Western blotting and relative
densitometric analysis for the neuronal death pathway and for Rho-family GTPases. Results are mean ± SE of 3 experiments (n = 3). *P < .05,
**P < .005 vs Normoxia; +P < .05, ++P < .005 vs I/R. Representative WB images are reported. Phosphorylated proteins are normalized upon their
respective total protein
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above genes (red circles) and related miRNAs (light-blue circles) are
displayed as well in a graph (Figure 5B, right).

Conversely, especially in the latter two pathways, several genes,
physiologically involved in promoting cell survival and proliferation,

Similarly, many genes known to be implicated in neuronal death,

were included in the list of miRNAs target genes as well. For this rea-

here presumed with decreased levels, are included and highlighted in

son, we hypothesize that even if supposed downregulated in our

the neurotrophin signaling pathway (complete list in File S4), in partic-

model, with consequent inhibition of such pathways, the complex

ular downstream p75NTR (Figure 6, left).

microenvironment, where they play their function, may influence the

Of note, among the target genes, there is RhoA, down-regulation

effective downregulation of these players. This phenomenon, how-

of which was also described by Western blotting in I/R + CM condi-

ever, can be expected, being miRNAs fine regulators at the epigenetic

tions (Figure 2B). Also, in this case, interactions among target genes

level, and thus contributing to the balance of different functions

playing a role in neuronal death (red circles) and related miRNAs

within a broad multitude of cell process networks. Furthermore, due

(light-blue circles) are shown in the graph (Figure 6, right).

to the complexity of such networks, even though we refer to an
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F I G U R E 3 Immunofluorescence for NFH and neurite analyses graphs. Bar = 10 μm. Results are mean ± SE of 3 experiments (n = 3).
***P < .0005 vs Normoxia; +++P < .0005 vs I/R. Representative IF images are shown

259

NEUROPROTECTIVE EFFECTS OF hAFSCs-DERIVED SCRETOME

T A B L E 1 Pathway-based analysis of
the 16 upregulated miRNAs in
conditioned media exosomes

KEGG pathway

P-value

#genes

#miRNAs

Hippo signaling pathway (hsa04390)

7.36E-08

103

16

TNF signaling pathway (hsa04668)

3.76E-05

78

16

mTOR signaling pathway (hsa04150)

6.70E-05

48

16

Neurotrophin signaling pathway (hsa04722)

.000235281

85

15

HIF-1 signaling pathway (hsa04066)

.000639284

75

16

Apoptosis (hsa04210)

.003465202

62

15

PI3K-Akt signaling pathway (hsa04151)

.019922794

209

16

MAPK signaling pathway (hsa04010)

.043639368

152

15

Axon guidance (hsa04360)

.04536589

78

16

Note: Only terms considered as the most relevant among the significant ones are reported.

experimentally supported database for miRNA-target genes interac-

target genes promoting cell proliferation was present, but also others

tions in in silico analysis, it has to be considered that also additional

with pro-apoptotic and anti-proliferative functions (complete list in

regulatory mechanisms able to define the cell fate can play a role. The

File S4), represented in the target genes/miRNA interaction graph

well-known PI3K-AKT survival pathway, already studied by Western

(Figure 6, right). Interestingly, most of those factors here hypothesized

blotting, was analyzed as well (Figure 6B). A relevant part of miRNA

to be downregulated as miRNAs targets, act downstream the major
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F I G U R E 4 A, Viability test upon I/R, I/R+ CM, exosomal component (EXO) and soluble component (CM w/o EXO). B, mBDNF levels through
ELISA kit and its relative standard curve. C, Western blotting analysis for mBDNF in the exosome protein lysates and CM w/o EXO. Results are
mean ± SE of 3 experiments (n = 3). *P < .05, **P < .005, **P < .0005 vs Normoxia; ++P < .005, ++P < .0005 vs I/R. Representative WB image is
reported. D, overexpressed miRNAs detected in hAFSC-CM derived exosomes. RQ ± SE values obtained are reported and shown in the
logarithmic (log10) scale
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player of this pathway, possibly further enhancing pro-survival and

with ischemic stroke.65,66 Consequently, defining the molecular mech-

proliferation processes.

anisms underlying the I/R injury can improve the success of reperfusion treatment and enhance the clinical advantages for patients with
stroke.67 Numerous biological processes involving calcium excess, oxi-

4

|

DISCUSSION

dative stress, inflammatory reactions, and endoplasmic reticulum
stress are closely related to the brain I/R injury.65,68

Ischemic stroke is one of the leading causes of morbidity, mortality,

Interestingly, each of these activities can be influenced by mito-

and disability in aging patients.64 Appropriate reperfusion of the ische-

chondria. In reply to the brain I/R injury, mitochondria cannot gener-

mic region is the standard approach to preserve brain structure and

ate sufficient energy and thus affect calcium reuptake by the

8

function. However, reperfusion approaches after ischemic stroke

endoplasmic reticulum, which induces calcium excess. Moreover,

trigger further brain injuries, described as cerebral I/R injury. I/R injury

alterations in mitochondria can be due to excessive ROS, which cau-

decreases the clinical benefits of reperfusion approaches for patients

ses oxidative stress.69 Consequently, altered mitochondria can
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F I G U R E 5 A, On the left, HIF-1 signaling pathway (modified from KEGG hsa04066), showing genes targeted by miRNAs (n = 16) involved in
its modulation. Orange boxes, genes targeted by more than 1 miRNA; yellow boxes, genes targeted by 1 miRNA and in green, not targeted genes.
The complete list of target genes is reported in File S3. On the right, the graph showing interactions between miRNAs and related target genes. B,
On the left, the Apoptosis pathway (modified from KEGG hsa04201), showing genes targeted by miRNAs (n = 15) involved in its modulation.
Orange boxes, genes targeted by more than 1 miRNA; yellow boxes, genes targeted by 1 miRNA and in green, not targeted genes. The complete
list of target genes is reported in File S3. On the right, the graph showing interactions between miRNAs and related target genes with proapoptosis and pro-inflammatory functions
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stimulate pro-apoptotic factors in the cytoplasm or the nucleus to

upregulated neuron-specific markers, such as β-tubulin III, Neu-

begin mitochondria-supported cellular apoptosis.70

rofilament 200, and GAP43.74

In the present study, for the first time, the efficacy of hAFSCs-

Previous reports demonstrated that in ischemic conditions, differ-

secretome in protecting cells by death signals in I/R in vitro model

ent pathways were altered, including PI3K/AKT, AKT/GSK-3β/β-

was studied.

catenin, ERK1/2, apoptotic pathways, mTOR pathway as well as

As mentioned above, the OGD/R model is a widely studied model

BDNF pathway.60,75,76

to mimic ischemia. Differentiated SH-SY5Y cells have been largely uti-

Mostly, MSCs or MSCs-CM administration showed structural and

lized to investigate neuronal activity since they have comparable mor-

functional advantages: it can diminish apoptosis at the injured area, to

phology and biochemical characteristics to mature neurons.71-73

modulate pro-inflammatory reaction, to offer a permissive environ-

Differentiation of SH-SY5Y cells with N2 supplement demonstrated

ment for axonal expansion, to stimulate neurogenesis and enhance
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F I G U R E 6 A, On the left, the Neurotrophin signaling pathway (modified from KEGG hsa04722), showing genes targeted by miRNAs (n = 15)
involved in its modulation. Orange boxes, genes targeted by more than 1 miRNA; yellow boxes, genes targeted by 1 miRNA and in green, not
targeted genes. The complete list of target genes is reported in File S3. On the right, the graph showing interactions between miRNAs and related
target genes involved in neuronal death. B, On the left, the PI3K-Akt signaling pathway (modified from KEGG hsa04151), showing genes targeted
by miRNAs (n = 16) involved in its modulation. Orange boxes, genes targeted by more than 1 miRNA; yellow boxes, genes targeted by 1 miRNA
and in green, not targeted genes. The complete list of target genes is reported in File S3. On the right, the graph showing interactions between
miRNAs and related target genes with anti-survival and anti-proliferative functions
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neurological impairments.36,77,78 The composition of the CM secret-

Further, within exosomal cargo, a broad variety of miRNAs has

ome “cargo” determines the therapeutic potential.79 CM contains a

been detected, which can influence functions associated with neural

variety of growth factors and tissue-regenerative agents, which were

remodeling and neurogenic processes. Several miRNAs, already

released by the stem cells. Indeed, proteomic studies showed the

identified as players in neuroprotective mechanisms (miR-146a-5p,

presence of various growth factors and other cytokines in the

miR-154-5p, miR-22-3p, miR-23a-3p, miR-27a-3p, miR-29a-3p, and

CM.80,81 Besides, MSCs are the most efficient exosome-producing

miR-31-5p), were also identified in our hAFSC-derived exosomes.

82

Interestingly, miR-146a was already described in the negative regula-

cells.

tion of inflammation90,91 and in promoting oligodendrogenesis92 in

lishes that the positive effects of stem cell therapeutic approach are

the post-injury perinatal brain. MiR-154 was detected in astrocyte-

due to stimuli of resident cells by the release of bioactive molecules

derived extracellular vesicles, involved in regulating neurotrophic

and EV, the use of secretome could offer several advantages over

signaling in neurons.93 Moreover, miR-154 is known to target DKK2

MSCs such as a superior safety profile. Different reports demon-

(Dickkopf-related protein 2) with consequent β-catenin up-regulation

strated that secretome released from MSCs could decrease cognitive

and classical Wnt signaling pathway activation,94 crucial both for the

impairments related to numerous neurological disease models, com-

maintenance of synaptic structures and neuronal survival.95 MiR-

prising Traumatic Brain Injury, Parkinson's disease, Alzheimer's dis-

22-3p, 23a, and 27a are involved in neuroprotection mechanisms

ease, and stroke.28,83-86 Secretome and conditioned media showed

through apoptosis inhibition96-100 Furthermore, miR-22-3p can

the ability to interact and promote the release of neurotrophins, com-

regulate neuronal morphology during migration by targeting the

prising vascular endothelial growth factor, BDNF. Nerve growth fac-

CoREST/REST complex,101 and miR-27a is involved in controlling

tor, improving neurite development, stimulating neurorestorative and

neuroinflammation.99 Also, among the other miRNA identified, miR-

78,87

neurological improvement.

29a was already described to protect against cell damage after

Exosome release is deemed an adaptation mechanism and its

ischemia-like stress and astrocyte ischemic injury102,103; miR-31-5p,

composition, biogenesis, and secretion are influenced by microenvi-

also identified in our exosomal component, is known to reduce the

ronment with which cells interrelate.

78,87

The high proliferative capacity, the low immunogenicity, and

inflammatory

response

and

oxidative

stress-induced

neuronal

damage104 and, further, shows pro-angiogenic activity.105

tumorgenicity and the anti-inflammatory activity support the hAFSCs

On the other hand, regarding other miRNAs here identified, such

use as safe and effective donor cells for stroke therapy.88 Further-

as miR-221-3p, miR-222-3p, miR-24-3p, and miR-28-5p, limited or

more, human stem cell utilization is useful and helpful for clinical trial

conflicting data about their function and implication in neuronal pro-

translation. In vitro systems have a partial capacity to reflect the com-

cesses have been reported.106-109

plicated situation that occurs during stroke in vivo. Still, they repre-

Besides neurotrophin signaling, interestingly, the pathway-based

sent a useful research tool to understand cellular and molecular

analysis revealed that these miRNAs act on pathways known to be

mechanisms that are difficult to dissect in vivo.

altered in ischemic conditions and involved in neuroprotection, such

Thus, the growing availability of human cells renders in vitro sys-

as TNF, Hippo, and PI3K.110-112 Among the miRNAs targets here

tems a solid low-cost base for the drug discovery pyramid and for

identified, supposed to be downregulated in our model, we

strengthened the in vivo research, improving clinical translation.

highlighted several genes involved in apoptosis and inflammation

In this study, we established an I/R model and analyzed the

processes.

downstream responses to hAFSC-secretome exposure. Our findings

Interestingly, based on the experimentally supported miRNAs/tar-

indicated that the CM and, in particular, the exosomal fraction played

get genes, in HIF-1 pathway, a sort of global switch-off mechanism

a crucial role in promoting cell survival. This pro-survival effect was

can be observed. In contrast, other pathways of interest, including

paralleled by the activation of the neurotrophic pathways BDNF/TrkB

apoptosis, neurotrophins, and PI3K-AKT, showed several groups of

and by the suppression of the death pathways (p75/JNK). These

genes, all supposed to be downregulated in response to miRNA activ-

effects were paralleled by the increase of the survival pathway PI3K/

ity, physiologically playing a role in inducing or, conversely repressing

Akt and ERK5.

different processes, such as proliferation, apoptosis, inflammation.

Exosomes encapsulate and transfer numerous functional mole-

This is, however, consistent with the pleiotropic and versatile activity

cules, including proteins, lipids, and regulatory RNAs, which can alter

and function of miRNAs, molecules specifically designated to regulate

cell metabolism.79 Notably, in the MSC-derived exosomes protein

and fine tune, at the epigenetic level, expression of multiple target

component, we identified a high level of mBDNF. Numerous studies

genes within complex molecular circuitries.113 Further studies are

showed that exosomes carry different neuronal proteins and that they

needed to confirm the involvement and biological impact of miRNAs

can cross the blood-brain barrier.89 However, till now, it was not clear

identified in this in silico study regulating neurogenic processes after

whether BDNF was present in the exosomes and the soluble compo-

stroke, as well as to shed light on molecular mechanisms underlying

nent of CM, and, interestingly, in our experimental condition, we

their possible neuroprotective role, even if the biochemical data

found that both exosomal fractions and soluble CM contains high

obtained strongly support the involvement of these miRNAs in regu-

levels of mBDNF, with exosomes particularly endowed of this

lating several actors of the analyzed pathways, that is, pro-BDNF,

neurotrophin.

PI3K-Akt, Rho/Rac.
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Based on this evidence, and on the paracrine theory which estab-
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The central nervous system includes various cells other than neurons, thus, undoubtedly it is important also to study the effect of the

ET HICS S TAT E MENT
Amniotic fluid was used upon informed written consent.

conditioned media derived from hAFSCs in vivo; future studies will be
devoted to clarify the therapeutic effect of hAFSCs-CM in stroke
in vivo models.
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of the exosomal cargo and that the effect of CM-derived exosomes
could be in part mediated by secreted miRNAs. Specifically, our
findings suggest that miRNAs may mediate neuroprotection mainly
through anti-apoptotic and pro-survival pathways. However, it is
conceivable that some effects may also be due to the soluble component of the CM, being this latter endowed by neurotrophic
activity.
Taking this into consideration, the use of CM, and in particular,
exosomes, may constitute a potential approach to stimulate neuronal plasticity, ameliorate cognitive loss, and neural replacement in
stroke. Consequently, it is possible to indicate that the exosomal
fraction of the hAFSC-CM may represent a suitable treatment for
I/R injury.
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